Targeting the NG2/CSPG4 Proteoglycan Retards Tumour Growth and Angiogenesis in Preclinical Models of GBM and Melanoma

• Jian Wang ,

  Contributed equally to this work with: Jian Wang, Agnete Svendsen

  Affiliation Translational Cancer Research Group, Department of Biomedicine, University of Bergen, Bergen, Norway

  ⨯
• Agnete Svendsen ,

  Contributed equally to this work with: Jian Wang, Agnete Svendsen

  Affiliation Translational Cancer Research Group, Department of Biomedicine, University of Bergen, Bergen, Norway

  ⨯
• Justyna Kmiecik,

  Affiliation Translational Cancer Research Group, Department of Biomedicine, University of Bergen, Bergen, Norway

  ⨯
• Heike Immervoll,

  Affiliations Haukeland University Hospital, Department of Pathology, Bergen, Norway, The Gades Institute, University of Bergen, Bergen, Norway

  ⨯
• Kai Ove Skaftnesmo,

  Affiliation Translational Cancer Research Group, Department of Biomedicine, University of Bergen, Bergen, Norway

  ⨯
• Jesús Planagumà,

  Affiliation Translational Cancer Research Group, Department of Biomedicine, University of Bergen, Bergen, Norway

  ⨯
• Rolf Kåre Reed,

  Affiliation Heart and Circulatory Research Group, Haukeland University Hospital, Bergen, Norway

  ⨯
• Rolf Bjerkvig,

  Affiliations Translational Cancer Research Group, Department of Biomedicine, University of Bergen, Bergen, Norway, Centre de Recherche Public de la Santé, Luxembourg, Luxembourg

  ⨯
• Hrvoje Miletic,

  Affiliations Translational Cancer Research Group, Department of Biomedicine, University of Bergen, Bergen, Norway, Haukeland University Hospital, Department of Pathology, Bergen, Norway

  ⨯
• Per Øyvind Enger,

  Affiliations Translational Cancer Research Group, Department of Biomedicine, University of Bergen, Bergen, Norway, Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway

  ⨯
• Cecilie Brekke Rygh ,

  ¶These authors also contributed equally to this work.

  Affiliations Translational Cancer Research Group, Department of Biomedicine, University of Bergen, Bergen, Norway, Heart and Circulatory Research Group, Haukeland University Hospital, Bergen, Norway

  ⨯
• Martha Chekenya

  * E-mail: martha.chekenya@biomed.uib.no

  ¶These authors also contributed equally to this work.

  Affiliation Translational Cancer Research Group, Department of Biomedicine, University of Bergen, Bergen, Norway

  ⨯